Phase IIIb study of durvalumab plus platinum-etoposide in first-line treatment of extensive-stage small cell lung cancer (CANTABRICO): Preliminary efficacy results

被引：3

作者：

Isla, D. ^{[1
]}

Arriola, E. ^{[2
]}

Garcia Campelo, M. R. ^{[3
]}

Diz Tain, P. ^{[4
]}

Marti Blanco, C. ^{[5
]}

Lopez-Brea Piqueras, M. M. ^{[6
]}

Moreno Vega, A. L. ^{[7
]}

Leon Mateos, L. A. ^{[8
]}

Oramas Rodriguez, J. M. ^{[9
]}

Gutierrez Calderon, V. ^{[10
]}

Majem Tarruella, M. ^{[11
]}

Sanchez Hernandez, A. ^{[12
]}

Aguado de la Rosa, C. ^{[13
]}

Alvarez Cabellos, R. ^{[14
]}

Marti Ciriquian, J. L. ^{[15
]}

Paul, A. Moreno ^{[16
]}

Firvida Perez, J. L. ^{[17
]}

Callejo Mellen, A. ^{[18
]}

Baez, L. ^{[19
]}

Paz-Ares, L. ^{[20
]}

机构：

[1] Hosp Clin Univ Lozano Blesa, Med Oncol, Zaragoza, Spain

[2] Hosp Mar, Parc Salut Mar, Med Oncol Dept, Barcelona, Spain

[3] Inst Invest Biomed A Coruna INIBIC, Med Oncol Dept, La Coruna, Spain

[4] Complejo Asistencial Univ Leon, Hosp Leon, Med Oncol Dept, Leon, Spain

[5] Hosp Univ St Joan Reus Reus, Med Oncol Dept, Reus, Spain

[6] HUMV Hosp Univ Marques Valdecilla, Med Oncol Dept, Santander, Spain

[7] Hosp Univ Reina Sofia, Med Oncol Dept, Cordoba, Spain

[8] Hosp Clin Univ Santiago de Compostela, Med Oncol Dept, Santiago De Compostela, Spain

[9] Hosp Univ Canarias, Med Oncol Dept, Tenerife, Canary Isl, Spain

[10] Hosp Reg Univ Malaga Carlos Haya, Med Oncol Dept, Malaga, Spain

[11] Hosp Santa Creu & Sant Pau, Med Oncol Dept, Barcelona, Spain

[12] Consorcio Hosp Prov Castellon, Med Oncol Dept, Castellon De La Plana, Spain

[13] Hosp Clin Univ San Carlos, Med Oncol Dept, Madrid, Spain

[14] Hosp Virgen Salud, Med Oncol Dept, Toledo, Spain

[15] Hosp Gen Univ Alicante, Med Oncol Dept, Alicante, Spain

[16] Hosp Galdakao Usansolo, Med Oncol Dept, Galdakao, Spain

[17] Ctr Med El Carmen, Med Oncol Dept, Orense, Spain

[18] AstraZeneca Farmaceut Spain S A, Med Dept, Madrid, Spain

[19] AstraZeneca Farmaceut Spain S A, Med Oncol Dept, Madrid, Spain

[20] Hosp Univ 12 Octubre, Med Oncol Dept, Madrid, Spain

来源：

ANNALS OF ONCOLOGY | 2022年 / 33卷 / 07期

关键词：

D O I：

10.1016/j.annonc.2022.07.1627

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1532P

引用

页码：S1247 / S1248

页数：2

共 50 条

[1] Durvalumab plus platinum-etoposide in first-line treatment of extensive-stage small cell lung cancer (CANTABRICO): A Spanish phase IIIb single arm, real-world study
Paz-Ares, L.
Arriola, E.
Campelo, M. R. Garcia
Tain, M. P. Diz
Blanco, M. C. Marti
Vega, A. L. Moreno
Leon-Mateos, L.
Calderon, V. Gutierrez
Hernandez, A. Sanchez
Rodriguez, J. M. Oramas
Majem, M.
De la Rosa, C. Aguado
Cabellos, R. Alvarez
Ciriquian, J. L. Marti
Amezcua, V.
Perez, J. L. Firvida
Mellen, A. Callejo
Baez, L.
Isla, D.
[J]. ANNALS OF ONCOLOGY, 2021, 32 : S1171 - S1172
[2] Phase IIIb study of durvalumab plus platinumeetoposide in first-line treatment of extensive-stage small cell lung cancer (CANTABRICO): Safety results
Casado, M. D. Isla
Arriola, E.
Garcia-Campelo, M. R.
Tain, P. Diz
Blanco, C. Marti
Piqueras, M. M. Lopez-Brea
Vega, A. L. Moreno
Mateos, L. A. Leon
Rodriguez, J. M. Oramas
Calderon, V. Gutierrez
Majem, M.
Hernandez, A. Sanchez
Aguado, C.
Cabellos, R. Alvarez
Ciriquian, J. L. Marti
Paul, A. Moreno
Perez, J. L. Firvida
Mellen, A. Callejo
Baez, L.
Paz-Ares, L.
[J]. ANNALS OF ONCOLOGY, 2023, 34 : S1063 - S1063
[3] Phase IIIb study of durvalumab plus platinumeetoposide in first-line treatment of extensive-stage small cell lung cancer (CANTABRICO): Treatment patterns of chemotherapy combination phase with durvalumab
Isla, D.
Arriola, E.
Garcia Campelo, M. R.
Marti, C.
Diz Tain, P.
Moreno Vega, A. L.
Piqueras, M. L-B.
Leon, L.
Gutierrez Calderon, V.
Oramas Rodriguez, J. M.
Majem, M.
Sanchez-Hernandez, A.
Aguado de la Rosa, C.
Alvarez Cabellos, R.
Marti-Ciriquian, J. L.
Moreno Paul, A.
Gonzalez Cordero, M.
Callejo Mellen, A.
Baez, L.
Zugazagoitia, J.
[J]. ANNALS OF ONCOLOGY, 2022, 33 : S98 - S99
[4] LUMINANCE: A Phase IIIb Study of Durvalumab plus Platinum-Etoposide for First-Line Treatment of Extensive-Stage SCLC (ES-SCLC)
Reinmuth, N.
DeMarinis, F.
Leighl, N.
Sadow, S.
Davey, K.
Ozguroglu, M.
[J]. JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S547 - S547
[5] First-line atezolizumab/durvalumab plus platinum-etoposide combined with radiotherapy in extensive-stage small-cell lung cancer
Li, Lijuan
Yang, Dan
Min, Yanmei
Liao, Anyan
Zhao, Jing
Jiang, Leilei
Dong, Xin
Deng, Wei
Yu, Huiming
Yu, Rong
Zhao, Jun
Shi, Anhui
[J]. BMC CANCER, 2023, 23 (01)
[6] First-Line Durvalumab Plus Platinum-Etoposide Versus Platinum-Etoposide for Extensive-Stage Small-Cell Lung Cancer: A Cost-Effectiveness Analysis
Zhang, Longfeng
Hang, Yongfu
Liu, Maobai
Li, Na
Cai, Hongfu
[J]. FRONTIERS IN ONCOLOGY, 2020, 10
[7] First-line durvalumab plus platinum-etoposide in extensive-stage small-cell lung cancer: CASPIAN Japan subgroup analysis
Katsuyuki Hotta
Makoto Nishio
Haruhiro Saito
Isamu Okamoto
Yasuharu Nakahara
Hidetoshi Hayashi
Manabu Hayama
Peter Laud
Haiyi Jiang
Luis Paz-Ares
Koichi Azuma
[J]. International Journal of Clinical Oncology, 2021, 26 : 1073 - 1082
[8] First-line durvalumab plus platinum-etoposide in extensive-stage small-cell lung cancer: CASPIAN Japan subgroup analysis
Hotta, Katsuyuki
Nishio, Makoto
Saito, Haruhiro
Okamoto, Isamu
Nakahara, Yasuharu
Hayashi, Hidetoshi
Hayama, Manabu
Laud, Peter
Jiang, Haiyi
Paz-Ares, Luis
Azuma, Koichi
[J]. INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2021, 26 (06) : 1073 - 1082
[9] Durvalumab plus platinum-etoposide versus platinum-etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial
Paz-Ares, Luis
Dvorkin, Mikhail
Chen, Yuanbin
Reinmuth, Niels
Hotta, Katsuyuki
Trukhin, Dmytro
Statsenko, Galina
Hochmair, Maximilian J.
Ozguroglu, Mustafa
Ji, Jun Ho
Voitko, Oleksandr
Poltoratskiy, Artem
Ponce, Santiago
Verderame, Francesco
Havel, Libor
Bondarenko, Igor
Kazarnowicz, Andrzej
Losonczy, Gyorgy
Conev, Nikolay V.
Armstrong, Jon
Byrne, Natalie
Shire, Norah
Jiang, Haiyi
Goldman, Jonathan W.
Batagelj, Emilio
Casarini, Ignacio
Pastor, Anea Viviana
Sena, Susana Noemi
Zarba, Juan Jose
Burghuber, Otto
Hartl, Sylvia
Hochmair, Maximilian J.
Lamprecht, Bernd
Studnicka, Michael
Schlittler, Luis Alberto
de Oliveira, Fabricio Augusto Martinelli
Calabrich, Aknar
Girotto, Gustavo Colagiovanni
Dos Reis, Peo
Gorini, Carlos Fausto Nino
De Marchi, Peo Rafael Martins
Baldotto, Clarissa Serodio da Rocha
Sette, Claudia
Zukin, Mauro
Conev, Nikolay V.
Dudov, Assen
Ilieva, Rumyana
Koynov, Krassimir
Krasteva, Rositsa
Tonev, Ivan
[J]. LANCET, 2019, 394 (10212): : 1929 - 1939
[10] Anlotinib plus platinum-etoposide as a first-line treatment for extensive-stage small cell lung cancer: A single-arm trial
Deng, Pengbo
Hu, Chengping
Chen, Cen
Cao, Liming
Gu, Qihua
An, Jian
Qin, Ling
Li, Min
He, Baimei
Jiang, Juan
Yang, Huaping
[J]. CANCER MEDICINE, 2022, 11 (19): : 3563 - 3571

← 1 2 3 4 5 →